ESR1 and breast carcinoma: Although α7-nAChR is the oncogenic receptor responsible for most of the oncogenic responses in cancer, α9-nAChR has been shown to be upregulated in estrogen receptor positive breast cancer cells, and α9-nAChR stimulates the initiation and progression of breast cancer in coalition with estrogen receptor [95].